cirm.ca.gov

Pluripotent Stem Cells for Tendon Tissue Engineering

Translational Candidate Modified synthetic noncoding RNA molecule Area of Impact Systemic Sclerosis Mechanism of Action The mechanism of action of TY1 is alleviating cell stress and damage through ...
cirm.ca.gov

Modulación de células madre alveolares humanas para promover la regeneración pulmonar y evitar la fibrosis pulmonar

Objetivo de la investigación Comprender los reguladores de la función de las células madre pulmonares alveolares humanas promoverá una regeneración pulmonar más normal después de una lesión y evitará ...
cirm.ca.gov

CIRM Training Program in Translational Regenerative Medicine

We propose a CIRM Scholars Training Program in stem cells and translational regenerative medicine for 4 PhD student, 8 postdoctoral (PhD) scientist and 8 clinical (MD) physician trainees. Training the ...
cirm.ca.gov

Alpha Clinics Network

The Alpha Clinics Network is funded and supported by the California Institute for Regenerative Medicine (CIRM). The Network features nine world-class medical centers throughout California with a ...
cirm.ca.gov

Public Meetings

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
cirm.ca.gov

CIRM approves over $111 million to support discovery and clinical research

The awards approved by the board support three clinical trial (CLIN2) grant applications with a combined approved total of $31M in financial support from CIRM. These grants fund clinical trials for ...
cirm.ca.gov

将干细胞研究与再生医学临床应用联系起来的培训计划

了解干细胞的发育和分化过程对于科研和生物制造至关重要，但现有方法无法实时追踪这一过程。为了解决这一难题，研究人员开发了一种利用荧光寿命成像（FLIM）结合机器学习技术来监测干 ...
cirm.ca.gov

CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases

South San Francisco, Calif., January 30, 2026 – The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside ...
cirm.ca.gov

News and Events

On a mission: A conversation with CIRM Board Vice Chair Maria Gonzalez Bonneville May 11, 2026 Maria Gonzalez Bonneville is dedicated to improving health in California through her roles at the ...
cirm.ca.gov

CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials

South San Francisco, CA, December 11, 2025 – The California Institute for Regenerative Medicine (CIRM) governing board today approved funding of over $160 million for 16 new research awards to develop ...
cirm.ca.gov

Funding Opportunities

At the California Institute for Regenerative Medicine (CIRM), we are committed to the continued funding of groundbreaking research in regenerative medicine. To reflect this commitment, we are ...
cirm.ca.gov

Sign Up for Updates

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.